The Full Spectrum of News.
Published loading...Updated

betaSense GmbH identifies new diagnostic biomarker for Parkinson’s - European Biotechnology Magazine

Summary by European-biotechnology.com
A new biomarker for Parkinson's disease makes it possible to recognise and treat the hereditary dopamine deficiency before the mid-brain is damaged, reports University Bochum spin-out betaSense GmbH. The post betaSense GmbH identifies new diagnostic biomarker for Parkinson’s appeared first on European Biotechnology Magazine.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Diario de Cádiz broke the news in on Monday, April 28, 2025.
Sources are mostly out of (0)

Similar News Topics